ArticleJPRAS open2026
Reducing the burden of breast implant infections through a structured multidisciplinary pathway.
Article in JPRAS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast implant-related infections are major complications of implant-based breast reconstruction, leading to implant loss, delays in adjuvant oncologic therapies, prolonged hospitalization, and increased healthcare costs. Despite their impact, management strategies remain heterogeneous, and evidence supporting structured preventive approaches is limited. This study evaluated the effect of a structured multidisciplinary pathway (CONMUL) on infection incidence and clinical outcomes. Methods: A single-center retrospective cohort study included patients who underwent mastectomy followed by implant-based breast reconstruction between January 2022 and December 2025. From January 2024, a multidisciplinary protocol integrating plastic surgeons and infectious disease specialists was progressively implemented, including standardized preventive measures, early specialist consultation, and shared management pathways. The primary outcome was the trend in postoperative infection incidence before and after CONMUL implementation. Secondary outcomes included explantation rates, implant salvage, reinfection, and time to explantation. Results: Overall, 927 patients (1102 reconstructed breasts) were included, and 98 breasts (8.9%) developed postoperative infection. Annual infection incidence peaked at 11.42% in 2023 and declined following CONMUL implementation, reaching 5.15% in 2025, corresponding to approximately 15 fewer infections per year. Once infection occurred, explantation remained the most frequent outcome, with no significant differences between multidisciplinary and standard management. Time to explantation and reinfection rates were comparable between groups. Conclusions: A structured multidisciplinary pathway was associated with a clinically meaningful reduction in postoperative breast implant infection incidence. While multidisciplinary management did not significantly change outcomes after infection onset, it functioned as an effective preventive, system-level strategy without compromising clinical safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.